HOME >> BIOLOGY >> NEWS
University of Alberta researcher looks for clues to mysterious disease

nd control flies and found the average climbing ability to be lower for the mutant males. Aside from locomotor defects, the mutants recapitulated major symptoms of the disease, A-T, including sensitivity to ionizing radiation and chromosome instability.

"If you want to study a conserved biological process, it makes sense to do it in a system where you can do all these genetic tricks," said Campbell of being able to create mutant proteins and manipulate such factors as temperature. "We have an excellent model for investigating the basic mechanisms of chromosome structural maintenance involving ATM, allowing us to study how ATM works in a meaningful developmental context."

Although a cure seems to be a long way off, using this system to understand more about how ATM works will offer more clues to treating the disease, said Campbell. "There are some serious efforts being made for treatment of A-T and what we learn may also make it easier to screen for known carriers," she said. "My hope is by fully understanding how ATM functions, at least we can look at improving the quality of life for those unfortunate to receive mutant alleles from both their parents. That's the million dollar question--how does ATM work, and we're slowly getting closer to understanding it."


'"/>

Contact: Phoebe Dey
phoebe.dey@ualberta.ca
780-492-0437
University of Alberta
23-Sep-2004


Page: 1 2

Related biology news :

1. Indiana University, EPA to study airborne PCBs
2. Northeastern University receives $12.4 million NSF grant for creation of nanomanufacturing institute
3. Washington University in St. Louis leads group studying aging process
4. Tufts University establishes $4 million dollar tissue engineering resource center
5. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
6. As informatics grows, Indiana University helps set research agenda
7. University of Arizona licenses patent for natural fungicide
8. Washington University in St. Louis plays key role in sequencing moss genome
9. University of Pittsburgh receives $10 million grant for head and neck cancer
10. Clemson University spin-off uses corn to make plastics, provide cleaner air
11. Carnegie Mellon University hosts ACS-PRF summer school on green chemistry

Post Your Comments:
(Date:4/17/2014)... One day about eight years ago, Katia Silvera ... and her father were on a field trip in a ... orchid they had never seen before. , Unable to identify ... The orchid turned out to be an unnamed species. ... silverarum . , "Lophiaris" is the genus name, comprising about ...
(Date:4/17/2014)... France have hit on a novel method to ... correct and most effective treatment possible., Kidney stones ... and developing world. If left untreated, apart from ... failure and other complications. In many patients treated ... a more effective pathological approach to diagnosis and ...
(Date:4/17/2014)... expression is the process whereby the genetic information ... such as proteins, which have numerous different functions ... an important intermediary during gene expression, by relating ... mechanisms involved in manufacturing proteins. , By ... molecules present in an organism at a given ...
Breaking Biology News(10 mins):Orchid named after UC Riverside researcher 2Orchid named after UC Riverside researcher 3Rapid and accurate mRNA detection in plant tissues 2
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that they ... Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn ... , Turkey and other members ... antibiotic for the treatment of bacterial infections including those ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company developing ... simulated embryonic conditions, today announced that they have entered ... for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent cell ... an amendment to the existing license between Histogen and ...
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 iLab Solutions, the ... as the new Director of Product Strategy. In this role, ... as iLab sub-teams to guide in the development of iLab ... provides the maximum possible benefit to the scientific community by ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2
Cached News: